ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

FDBK Feedback Plc

18.25
-0.50 (-2.67%)
03 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Feedback Plc FDBK London Ordinary Share
  Price Change Price Change % Share Price Last Trade
-0.50 -2.67% 18.25 10:38:53
Open Price Low Price High Price Close Price Previous Close
18.75 18.25 18.75 18.25 18.75
more quote information »
Industry Sector
ELECTRONIC & ELECTRICAL EQUIPMENT

Feedback FDBK Dividends History

No dividends issued between 05 Jan 2015 and 05 Jan 2025

Top Dividend Posts

Top Posts
Posted at 04/1/2025 15:29 by jamescopperking
Could be major news for FDBK and BLEEPA.

Under the changes, hundreds of thousands of patients will be able to get direct referrals for checks through their GP for conditions including breathlessness, asthma, post-menopausal bleeding, hearing loss, tinnitus, urological conditions and bowel issues, removing the need to see a consultant first.
Posted at 22/12/2024 15:57 by jamescopperking
Yump

Quite an immature response.. I get it that you dislike FDBK and for whatever reason you like to always post negativity.

Do you agree it is an odd vacancy to post without any established business?
Posted at 22/12/2024 14:21 by jamescopperking
How many staff does FDBK employ in India?

Does FDBK have any current business in India?

Read post on another site that FDBK is recruiting for an Integration and Customer support engineer in India. I didn't think there was any existing business in India, so this job posting is quite interesting
Posted at 18/12/2024 14:42 by ducatiman
Good luck with that Jck there will be a move up as we approach April and Walter gives the nod and wink to upcoming contracts and FDBK taking over the running of the NHS. After that? Penny share and a consolidation?
Posted at 18/12/2024 14:09 by jamescopperking
I am expecting FDBK to make an explosive move during q125. I'm expecting 75p plus in short order
Posted at 04/12/2024 15:25 by ged5
I like your enthusiasm James, but several holders here were also here just over three years ago to hear TO say this:-

"well we are addressing a total available market in excess of 10 Billion globally, I think that the CDC opportunity is a total addressable market of about 93 Million, here within UK, so a sizable figure, especially considering we are now live with the exemplar site right at the front runner of that, we are … very well positioned for it, and in India with the TB opportunity is enormous"

You can read the full transcript in the Sunday Roast given to us by a past poster, Ragnarr. Hope he's doing OK, not heard from him for a long time.

There have also been other pieces of over exuberance notably before a fundraise. Some have reduced over the years, in my case quite considerably, because of the false dawns. So forgive us for not being taken in by this latest spiel.

I really do hope this comes good but until the contracts start flowing in then I'm afraid this is just a hold for me. But I hope you do well with it.

By the way 40+m mkt cap equates to 91p + share price Pedantics I know.

Good grief, Yump I thought I was pessimistic about FDBK. You take it to a different level!
Posted at 02/12/2024 13:13 by ged5
I realise a number of us have become disillusioned with FDBK and are very sceptical about Oakley's pitch and what you've posted does seem to be correct.

What I'm looking at is a substantial increase in holding by Cranston, increase by several directors both in the placing and in the market and small purchases by Oakley and Patel. Even Eschauzier has bought back the ones he sold by mistake.

Seguro Nominees have reduced but Canaccord have made an initial purchase.

Not sure if Charlton has increased or decreased and Hayball hasn't bought any that I can see. If those two have bought some I'd feel more confident about future success for FDBK.

Even so it's made me wonder with these director buys and a long standing holder such as Cranston giving further backing whether there is likely to be a change of fortune come April.

Let's see if I'm brave/foolish enough to purchase more when I have available funds.
Posted at 02/12/2024 10:18 by yump
You’ll have to second-guess when the vast number of 20p holders will bail then.

Unless they say otherwise, the cash is going to be used very quickly, because they’re having to fund each system, with no monetary contract and then hope they get enough patients through to get the per-patient cash.

They are also “selling”; (cough), to primary care, which is arguably more overworked, more fragmented and with less project staff than NHS trusts.

I may be fed up with FDBK, but those are the facts of the current situation.

To be fair, they do have an MOU for a pilot. That must be worth at least erm, well, pick a figure in the billions because it could be a whole new operational model for the NHS, funded by FDBK shareholders.
Posted at 04/11/2024 07:51 by yump
But TO says “there’s no better time to invest in the company”.

I guess that’s why the issue price is 20p.

I think a few of us thought a placing would be coming because the new amazing collaboration only gets paid per patient.

So FDBK have to install Bleepa/Carelocker at their expense and hope enough clinicians use it with patients to make it pay.

All the financial risk is now with FDBK.

Written off my investment. This will die a long slow death.
Posted at 16/10/2024 06:40 by yump
Sort of good news - perhaps.

So ring fenced and diverted capital budgets are supposedly an obstacle. Now there is a fund in revenue spend for diverting patients away from normal outpatient process.

That doesn’t answer the question of how many trusts are interested but stuck with the capital spend problem.

That is what I want to know. We have never been told that crucial information.

It also doesn’t cover the overall process of implementing Bleepa in a location, because its per-patient funding.

Can a trust get advance funding for a prospective number of patients, or does FDBK have to carry the implementaion spend/effort before any cash is forthcoming - and that depends on patient flow. So is there a contract committment from a trust ? Without it FDBK will be like a charity and so will shareholders.

The fact that they need an implementation partner makes me think they have been useless in getting even committment in principle from more tham a handful of trusts.

Your Recent History

Delayed Upgrade Clock